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Characterization of Gene Expression Profiles of Normal Canine Retina and Brain
Using a Retinal cDNA Microarray
Abstract
Purpose: Construction of a canine retinal custom cDNA microarray for comprehensive retinal gene
expression profiling and application for the identification of genes that are preferentially expressed in the
retina and brain lobes using a brain pool reference tissue.
Methods: A cDNA microarray was constructed utilizing clones obtained from a normalized canine retinal
expressed sequence tag library. Gene expression profiles were analyzed for normal retina, as well as the
cortex of the frontal, occipital, and temporal brain regions. Each sample was studied against a reference
sample of pooled brain RNA. Data from a quantified scanned image were normalized using the loess
subgrid procedure. Retina-enriched genes were identified using the Significance Analysis of Microarrays
(SAM) algorithm, and confirmed by northern blot analyses for selected genes. Differences between
biological samples were displayed using principal component analysis (PCA).
Results: Expression profiles for each tissue set were analyzed against the common reference of pooled
brain. Changes in expression between the sample and the reference were higher in the retina (27.9%) than
the individual brain tissues (2-6.6%). Furthermore, all individual retinal samples were clearly separated
from any of the hybridizations using brain tissue in the PCA. The accuracy of observed changes in
expression has been confirmed by northern blot analysis using five randomly chosen genes that
represented a wide range of different expression levels between retina and brain.
Conclusions: We have established an accurate and robust microarray system suitable for the
investigation of expression patterns in the retina and brain. Characterization of the gene expression
profiles in normal retina will facilitate the understanding of the processes that underline differences
between normal and diseased retinas.
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Characterization of gene expression profiles of normal canine retina
and brain using a retinal cDNA microarray
Gerardo L. Paez,1 Kimberly F. Sellers,2 Mark Band,3 Gregory M. Acland,4 Barbara Zangerl,1 Gustavo D. Aguirre1
1
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Genomics, University of Illinois, Urbana, IL; 4Baker Institute, College of Veterinary Medicine, Cornell University, Ithaca, NY
2

Purpose: Construction of a canine retinal custom cDNA microarray for comprehensive retinal gene expression profiling
and application for the identification of genes that are preferentially expressed in the retina and brain lobes using a brain
pool reference tissue.
Methods: A cDNA microarray was constructed utilizing clones obtained from a normalized canine retinal expressed
sequence tag library. Gene expression profiles were analyzed for normal retina, as well as the cortex of the frontal,
occipital, and temporal brain regions. Each sample was studied against a reference sample of pooled brain RNA. Data
from a quantified scanned image were normalized using the loess subgrid procedure. Retina-enriched genes were identified using the Significance Analysis of Microarrays (SAM) algorithm, and confirmed by northern blot analyses for selected genes. Differences between biological samples were displayed using principal component analysis (PCA).
Results: Expression profiles for each tissue set were analyzed against the common reference of pooled brain. Changes in
expression between the sample and the reference were higher in the retina (27.9%) than the individual brain tissues (26.6%). Furthermore, all individual retinal samples were clearly separated from any of the hybridizations using brain tissue
in the PCA. The accuracy of observed changes in expression has been confirmed by northern blot analysis using five
randomly chosen genes that represented a wide range of different expression levels between retina and brain.
Conclusions: We have established an accurate and robust microarray system suitable for the investigation of expression
patterns in the retina and brain. Characterization of the gene expression profiles in normal retina will facilitate the understanding of the processes that underline differences between normal and diseased retinas.

The domesticated dog, Canis familiaris, exhibits a diverse repertoire of morphological and behavioral characteristics that define the numerous specific breeds. This segregation, in effect the creation of genetic isolates, has resulted in
the emergence of autosomal recessive inherited canine diseases that are often directly comparable to those observed in
humans. Many of these affect the retina and result in a large
group of genotypically distinct retinal disorders representing
molecular and phenotypic counterparts in humans. By far the
largest group of diseases in dog, termed progressive retinal
atrophy (PRA), serve as disease homologs for retinitis
pigmentosa (RP) in humans [1]. Although the final common
pathway of photoreceptor degeneration in many retinal degenerative processes appears to be apoptosis [2-4], it is likely
that differing mechanisms link the causative mutations to the
cell death processes. Insights into these mechanisms are critical to develop therapeutic strategies, and these studies are dependent on animal models. One approach to examine the pathways involved in retinal degenerative diseases in animal models is gene expression profile analysis with the aim of identifying early alterations in gene expression that contribute to
photoreceptor cell death [5]. The microarray technology shows
Correspondence to: Barbara Zangerl, Section of Ophthalmology,
School of Veterinary Medicine, University of Pennsylvania, 3900
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potential as a useful tool to identify genes and gene pathways
involved in ocular disease progression and may therefore aid
in the characterization and classification of these diseases,
possibly identifying a common mechanism linking disorders
into groups [6,7].
Microarrays have been useful in the simultaneous analysis of transcript levels of thousands of genes in different physiological states of an organism, tissue, or cell [8,9]. Construction of microarrays is most efficient when information is utilized from annotated genomes or expressed sequence tags
(ESTs) and has led to new insights into animal development,
cancer, infectious diseases, and aging [10-12]. A major limitation of the technique is the analysis of sequences represented
on the array. This disadvantage is particularly problematic
when analyzing highly specialized tissues such as the retina
due to the repertoire of uniquely or preferentially expressed
genes contributing to its structure and function. In the case of
“orphan” species, commercial arrays are either not available
or targeted to a broader research community and
underrepresent the tissue of interest. The current available
canine microarray is based on transcripts representing 11
nonretina tissues and gene predictions not supported by experimental data (Affymetrix Genechip® Canine Genome Array, Santa Clara, CA). To obtain insight into intrinsic processes
of the canine and human retina, great efforts are directed toward the identification and characterization of transcripts with
functional relevance to this tissue [13-15]. Despite these ad-
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vances, a remaining challenge is to obtain an expression map
of the canine retina/retinal pigmented epithelium
transcriptome, further facilitating the identification of retinal
susceptibility genes but, most importantly, offering an invaluable resource for functional genomics studies.
To overcome these limitations and drive the development
of the canine retina transcriptome, we selected about 4,500
genes from a normalized canine retinal EST database [16].
These were used to construct a canine retinal cDNA microarray
for expression profiling of genes that are of interest in studies
of normal development and function and pathological conditions of the retina. As the brain and retina have a common
embryological origin, a brain pool was initially validated as a
reference sample for comparing expression profiles in multiple samples from animals with different molecularly defined
retinal diseases and at different stages of the disorders. As part
of this study, we have compared gene expression profiles between normal retina and different regions of the brain cortex
(frontal, occipital, temporal) to identify those genes preferentially expressed in either tissue. The overall aim of this study
is the identification of retina specific gene expression patterns
that will maximize the use in a variety of PRA dog models
[1].
METHODS
Tissue collection and RNA preparation: Retinas and brain
samples were collected from three 16-week-old normal beagles
(two males and one female) that were part of a specific-pathogen-free (SPF) colony at Cornell University. In addition, retinas and spleen samples were obtained from two 16-week-old
crossbred dogs (one male and one female) that were part of
NEI/NIH sponsored projects (R01EY06855, R01EY13132)
and were kept at the Retinal Disease Studies Facility (RDSF)
in Kennett Square, PA. All dogs were housed in an indoor
kennel under 12 h cyclic light conditions, and eyes were collected at a single time period (noon) to avoid potential fluctuations in retinal gene expression with time of day [17-22].
Both eyes were enucleated from the light-adapted dogs following intravenous anesthesia with sodium pentobarbital, and
the dogs were euthanized after enucleation with an overdose
of the barbiturate. The retinas were collected within 1-2 min
after enucleation, and brain and spleen samples obtained within
5-10 min after euthanasia; all tissues were flash frozen in liquid nitrogen and stored at -80 °C until use. The research was
conducted in full compliance with the ARVO Resolution on
the Use of Animals in Research.
RNA isolation: Total RNA was isolated using Trizol reagent (Invitrogen, Carlsbad, CA) and further purified by
RNeasy mini kit (Qiagen, Valencia, CA). Purity and RNA
quality were evaluated by absorbance at 260 nm and by denaturing formaldehyde agarose gel electrophoresis. High quality RNAs with A260/A280 ratio over 1.8 and intact 28S and 18S
RNA bands were used for microarray analysis. To generate an
RNA reference sample for microarray hybridizations, we
pooled equal amounts of total RNA from the cortex of the
occipital, temporal, and frontal brain regions collected from
three 16-week-old beagles to achieve a homogeneous pool of

transcripts. The pooled RNA was divided into aliquots (2 µg/
µl) and stored at -80 °C until use. For the purpose of this work,
four tissue groups have been established, containing five biological replicates for normal retina and three for each respective brain region. After initial validation of reproducibility,
only one microarray experiment was used for each sample.
Microarray construction: For microarray production,
3,931 “UniGene” sequences are represented by individual
clones from a canine retinal EST library [16]; another 120
unique sequences were added by two clones each to ensure
complete coverage of cDNA. In addition, about 300 genes
resulting from retinal subtraction libraries [16] or serving as
controls were printed on the microarray. Each clone was picked
from glycerol stocks manually, inoculated in 50 µl of LB Broth
Base (Invitrogen) with 100 µg/ml ampicillin and grown overnight at 37 °C. PCR was performed in two 15 µl reactions for
each clone by dipping the template into a master mix (1.5 µM
MgCl2, 0.2 µM dNTP, 0.4 µM of each primer [T7: 5'-TAA
TAC GAC TCA CTA TAG GG-3'; Sp6: 5'-ATT TAG GTG
ACA CTA TAG-3'] and 1 U Taq polymerase) with a replicator,
and amplified for 40 cycles at 94 °C for 10 s, 54 °C for 20 s
and 72 °C for 1 min, after an initial denaturing step at 95 °C
for 1 min, and followed by a final extension at 72 °C for 10
min. PCR products for each clone were pooled and purified
using Millipore Montage PCR384 Filter Plates (Millipore,
Billerica, MA). PCR products were resuspended in 50 µl of
distilled water, and 6 µl were run on a 1% agarose gel. Rhodopsin, (RHO), and β-Actin (ACTB) were used as positive controls, while microsatellite locus CUX20001 [23] was used as
a genomic control spot. All PCR products plus Array Control™ PCR Spots (Ambion, Austin, TX; spots 1-8) were spotted on Telechem superamine glass slides (TeleChem International, Inc., Sunnyvale, CA) using a Cartesian Pysix 5000
printer.
Microarray hybridization and scanning: Ten µg of pooled
canine brain total RNA was hybridized against 10 µg of the
respective test sample. Tissues were fluorescent-labeled using an indirect labeling protocol (3 DNA Array Kit,
Genesphere, Inc. Hatfield, PA) following the manufacturer’s
protocol. Hybridization signals were visualized with Cy5 and
Cy3 fluorescent reporter molecules, and intensities were detected using a GenePix 4000B Scanner (Molecular Devices
Corporation, Union City, CA). Scanned images were processed
using GenePix Pro version 6.0 (Molecular Devices Corporation, Downington, PA). The main quantities of interest produced by the image analysis (segmentation and background
correction) are the (R, G) fluorescence intensity pairs for each
gene on each array (R=red for Cy5, and G=green for Cy3).
Loess (locally weighted regression) normalization was performed to remove systematic variation that occurs in every
microarray experiment. An MA plot was used to represent the
(R, G) data, where M=log2 (R/G) and A=log2(RG) [24]. For
complete consideration surrounding the normalization process,
loess normalization over the entire chip, and block-specific
loess normalization followed by additional scaling via maximum likelihood estimation (MLE) or median absolute deviation (MAD) were also studied.
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Statistical analysis: Each hybridization was annotated
according to MIAME (Minimal Information About a
Microarray Experiment) standards, and analyzed with
GeneSpring version 7.2 (Silicon Genetics, Agilent Technologies, Palo Alto, CA; GPL3951, GPL3957, and GSE5208).
Controls were used for quality control and normalization of
the microarrays using GeneSpring, but ignored for the statistical data analysis. Significant changes in expression were identified with Significance Analysis of Microarrays (SAM, 1.15,
Stanford University, Palo Alto, CA) [25] at a delta value resulting in a false discovery rate (FDR) of less than 10%. Only
statistically significant changes will be reported here; however, the entire dataset is available from the authors on request.
Principal component analysis (PCA) was performed on a
complete microarray dataset consisting of log-transformed expression values for each individual replicate. As a result, the
dimensionality of the dataset was reduced and described in a
series of axes that explain the variance within the data. In this
analysis, 30.4%, 16.98%, and 14.1% of the variance within
the data was accounted for by the X, Y, and Z axes, respectively. These were used to plot the data and give an impression of the variation between the individual datasets; distances
between points on the graph are indicative of the differences
between replicates.
Northern analysis: Northern analysis was used to confirm expression patterns observed in the microarray data. Total RNA (10 µg) from brain (equal representation of frontal,
temporal, and occipital cortex regions), retina and spleen were
separated on a 1% formaldehyde-agarose gel and transferred
to a membrane (GeneScreen Plus Hybridization Transfer Membrane, Perkin Elmer Life Sciences, Inc. Boston, MA). The RNA
was crosslinked to the membrane and hybridized to purified
cDNA probes labeled with [α32P] dCTP using a DNA-labeling system (RadPrime DNA Labeling System, Invitrogen) at
68 °C overnight using ExpressHyb Solution (Clonetech, Palo
Alto, CA), and washed in 2X SSC, 0.05% SDS, and 0.1%
SSC, 0.05% SDS for 40 min each.
Probes for northern analysis were obtained by RT-PCR
with primers designed from the corresponding cDNA clone
information [16] (Appendix 1). For RT-PCR, 0.5 µg of total
RNA was incubated in a reaction mixture containing primer
(50 µM oligo(dT) 20, or 50 ng/µl random primer), 10 µM of
dNTPs mix, 40 U/µl of RNase inhibitor, ThermoScript™ RT
(15 U/µl; Invitrogen), 25 mM of MgCl2 10X cDNA synthesis
buffer in a final volume of 25 µl. The samples were incubated
at 70 °C for 5 min to denature the RNA then put on ice and
amplified as follows: 94 °C, 1 min; 50-63 °C, 1 min; 72 °C for
1 min, for 35 cycles. The RT-PCR product was fractionated
by electrophoresis on a 1.4% agarose gel containing 1 µg/ml
ethidium bromide in 1X TAE buffer. Each membrane was also
hybridized with canine ACTB cDNA to normalize for RNA
loading, and image intensities of the blots were quantified using
a Bio-Imaging Analyzer-BAS 1000 (Fujifilm life Science,
Tokyo, Japan) and its associated software.
1050

RESULTS
We produced a custom-made microarray chip featuring about
4,500 retina-specific genes to investigate expression profiles
of the retina. First experiments evaluating reproducibility found
negligible variance between technical replicates (data not
shown). To allow cross-comparison between multiple conditions, the experiment was arranged as reference design thus
allowing for an equal standardized error between each individual comparison and avoiding dye bias. Therefore, each biological sample was hybridized only once. Given the differences in test and reference sample, different normalization
approaches were considered: block-specific loess normalization (subgrid normalization), general loess normalization on
the entire array (global normalization), and subgrid loess normalizations followed by either a MLE or MAD scaling procedure (Appendix 1). This confirmed that the subgrid normalization, as performed by GeneSpring, did not introduce data
bias, and was used for the presented results.
The canine retinal cDNA microarray was used to identify
genes preferentially expressed in normal 16-week-old retina
in comparison to a pooled brain reference sample. Quantitative differences in the level of gene expression are illustrated
in a scatter plot (Figure 1) comparing the expression level for
normal retina (X-axis) versus the expression level from the
brain pool (Y-axis). High abundance of tissue-specific transcripts is observed in spots located outside the two-fold expression lines (Figure 1, lines 2 and 3). SAM was used with a
FDR of 10%, to confirm that 13.2% of 3,070 valid genes
strongly hybridized to retinal cDNA targets, implying that 405
genes on the microarray are preferentially expressed in the
normal retina (Table 1, Appendix 1). Of the remainder, 2,213
transcripts showed equal expression between normal retina
and the brain pool reference tissue, and 14.7%, 452 genes,
were less abundant in the retina (Table 2). Note that we call
the spotted DNA sequences “genes” whether they correspond
to actual genes or ESTs.
To further characterize the genes found to be preferentially expressed in brain, we hybridized the same brain pool
against cortex of frontal, occipital, and temporal brain regions
of three the different animals. Three percent of 3,489 valid
transcripts hybridized preferentially with the frontal region;
this corresponds to 114 genes highly expressed in the frontal
cortex. The occipital and temporal regions, respectively, had
22 and 20 genes (of 2,089 and 2,289 valid transcripts, respectively) that were more abundant. Most transcripts were unique
to a single cortex area (Figure 2A, Table 3), and only two
genes were upregulated in all three brain regions
(DR010012A10F04, TM4SF1). Transcripts less abundant than
in the pooled reference also demonstrated a low overlap between brain regions (Figure 2B, Table 4), with one gene
downregulated in all three brain cortex areas (FLJ10159).
The obtained expression profiles were analyzed using PCA
revealing independent clustering of experiments derived from
retinal and brain samples (Figure 3). The PCA profile demonstrates that a specific normal retinal gene expression profile
differs from the expression profiles of the frontal, occipital,
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Figure 1. MA-plot comparing gene expression in retina
and brain reference pool.
Each point represents a
single transcript/spot on the
array, plotted as a function
of its signal amplitude (expression level) for brain pool
and retina. Line 1 denotes
equivalent expression in
retina and brain, whereas
lines 2 and 3 indicate a twofold difference in the signal
strength. For illustration,
spots representing Rhodopsin, much more abundant in
retina than brain, are located
within the red circle, while
the uniformly expressed βActin spots lie within the
blue circle.

TABLE 1. FUNCTIONAL ANNOTATION OF THE TOP 30 RETINA-ENRICHED GENES
Clone
identifier
-------------DR010009B10H06
DR010020A20B07
DR010017A21C10
DR010018A20D11
DR010017A21D08
DR010024A10D06
DR010013B10A12
DR010015B10D11
DR010030A20H09
DR010008B20F12
DR010023B10C07
DR010022A20E08
DR010018B20H08
DR010008B20G12
DR010028B20H07
DR010028B10E10
DR010029A10E09
DR010009B10A10
DR010022B20B07
DR010021B20E07
DR010019B20C09
DR010014B20E10
DR010011A20D01
DR010005B10H02
DR010016B20C07
DR010024B10C12
DR010017B10E11
DR010027B20E09
DR010006B20G02
DR010029B10D10
DR010007A10G09

GenBank
access
number
-------DT538190
DT540322
DT539700
DT539956
DT539707
DT541291
DT538991
DT539417
DT543034
DT538002
DT541135
DT540832
DT540046
DT538006
DT542573
DT542509
DT542612
DT538119
DT540940
DT540724
DT540148
DT539271
DT538558
DT537179
DT539561
DT541427
DT539798
DT542265
DT537497
DT542720
DT537586

Dog chromosome location
-----------------------25:47,884,218-47,884,349
14:21,958,280-21,958,543
7:22,113,973-22,114,385
15:54,570,842-54,571,430
20:8,475,328-8,475,483
11:9,365,437-9,365,294
3:94,958,572-9,958,849
18:64,384,884-64,385,136
4:35,677,194-35,677,735
20:53,894,125-53,894,570
17:37,457,058-37,457,430
12:51,422,323-51,422,562
2:87,515,835-87,515,994
7:69,939,004-69,939,305
27:4,960,724-4,961,087
17:51,086,234-51,086,428
6:19,524,381-19,524,521
28:32,984,199-32,984,621
8:35,335,208-35,335,594
20:38,082,009-38,082,300
14:58,294,157-58,294,685
5:37,315,043-37,315,421
18:9,132,499-9,132,941
5:59,339,081-59,339,539
2:74,241,431-74,241,808
22:7,990,538-7,990,876
23:35,612,629-35,613,006
12:67,236,366-67,236,647
2:78,953,814-78,954,066
26:11,674,727-11,675,099
33:26,792,981-26,793,197

Gene
symbol
------SAG
GNAT1
PDC
SFRP2
RHO

Gene ID
number
------6295
2779
5132
6423
6010

PDE6B
ROM1

399653
6094

RDH8
DUSP2

50700
1844

CLUL1
NEUROD4
NLR
KCTD13
INPP5F
OTX2
LRTM1

27098
58158
4901
253980
22876
5015
57408

ECOP
GNB1
HMG-17
HMGN2

81552
2782
403686
3151

GLTP
DDOST
PPP1CC

51228
1650
5501

Human
chromosome
------------2q37.1
7q12.3
1q31.1
4q31.3
3q21-q24
9q32
10p14
11q12.3
10q23.1
19p13.2
2q11.2
6q15
1p36.22
18p11.32
12q13.2
14q11.1-q11.2
16p11.2
10q26.12
14q21-q22
3p14.3
7q31.2
6p21.1
7p11.2
1p36.33
13p25.1
1p36.11
11q12.3
12q24.11
1p36.12
12q24.11
3q13.33

Unigene
-----------------Hs.308 Cfa.7077
Hs.648519 Cfa.3191
Hs.580 Cfa.1202
Hs.481022
Hs.247565 Cfa.7396
Hs.150406
Hs.59872 Cfa.3793
Hs.281564
Hs.272405
Hs.1183
Hs.520287
Hs.439194
Hs.274959 Cfa.3516
Hs.131010
Hs.89606
Hs.534590
Hs.369755
Hs.288655
Hs.554867
Hs.239676
Hs.488307
Hs.430425
Hs.477784 Cfa.3549
Hs.181163
Hs.BC041359
Hs.381256
Cfa.3884
Hs.79081 Cfa.451
Hs.333358

Retina/brain
fold change
-----------37
36.5
36
31.5
27.5
26
25
24.5
23
21
20.5
16
11
9.30
9.5
9
9
6.5
6
6
5
5
4.5
4.50
4
4
4
4
3.5
3.5
3.5

Function
---------------------------Rhodopsin-mediated signaling
Transport, visual system
Signal, visual system
Unknown
Signal, visual system
EST
Signal, visual system
Disk morphogenesis
EST
Transport, visual system
Nucleic acid metabolism
EST
EST
Unknown
Metabolism
DNA, visual system
DNA metabolism
Metabolism
Metabolism
Sensory organ development
EST
EST
Signal transducer activity
Signal transducer activity
Nucleic acid
Nucleic acid
EST
Transport
Metabolism
Metabolism
EST

The top 30 genes with preferential retinal expression in a retina-brain pool comparisons are listed, with the corresponding identifiers, chromosomal location, expression ratio, and function. Hs represents Homo sapiens, Cfa represents Canis familiaris.
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and temporal cortices of the brain, while these clusters are
closely related. Within groups, experiments showed little variation, and the retinal profiles did not significantly differ with
regard to litter or sex of the tested individuals. The brain lobe
regions showed tissue-specific expression patterns, but one
temporal sample was clearly separated. The result was confirmed by independent replication of the experiment and could
represent an individual variation in this particular sample or
an experimental artifact.
To confirm the microarray results, we selected five genes
for northern analysis based on their microarray expression profiles. Two showed preferential expression in retina
(NEUROD4, DR010030A20H09), two in brain (SYN2, SPP1),

and one was equally expressed in retina and brain
(DR010024A20G01). Blots of total RNA from retina, brain,
and spleen were hybridized with cDNA probes for these five
genes (Appendix 1). We found that the northern blots showed
the same expression patterns predicted by the microarray data
with no detectable signal in spleen for any of the five genes
(Figure 4A). Semiquantitative determination of expression in
the northern blots correlated closely with the signal pattern
obtained from the microarray experiments (Figure 4B).
DISCUSSION
We have undertaken the first step in the evaluation of the normal canine retinal expression profile to create a system that

Figure 2. Region-dependent
expression pattern for frontal,
occipital, and temporal brain
cortices. The diagrams show
the number of genes up- (A)
and downregulated (B) in the
respective regions.

TABLE 2. FUNCTIONAL ANNOTATION OF THE 30 TOP BRAIN ENRICHED GENES
Clone
identifier
-------------DR010023A20H05
DR010027A10F10
DR010005A20E04
DR010008A20A02
DR010010B10C05
DP010005000E06
DR010027B20A04
DR010014B20F03
DR010015A20E10
DR010019A20H03
DR010024A10E09
DR010024B10F05
DR010026A20H08
DR010013A10A11
DR010022A10B01
DR010020A10B08
DR010025B10A02
DR010026B20G05
DR010025A21C11
DR010015A20E09
DR010016B10H12
DR010005B10E03
DR010012B20D10
DR010020A20D02
DR010024A20H05
DR010010A20G08
DR010013B10A11
DR010013A10E12
DR010028A20D02
DR010012B20E05

GenBank
access
number
-------DT541102
DT542045
DT537067
DT537874
DT538398
DT536078
DT542218
DT539277
DT539376
DT540130
DT541302
DT541444
DT541827
DT538911
DT540751
DT540252
DT541635
DT541971
DT541582
DT539375
DT539539
DT537156
DT539065
DT540337
DT541397
DT538371
DT538990
DT539022
DT542393
DT538877

Dog chromosome location
-------------------------X:80,243,963-80,244,545
4:14,326,600-14,327,069
32:13,862,656-13,862,983
20:40,129,412-40,129,709
6:62,422,039-62,422,316
20:9,218,236-9,413,008
16:55,443,443-55,443,919
13:30,167,584-30,167,884
35:9,024,760-9,025,290
24:15,030,049-15,043,202
26:31,587,239-31,587,700
4:69,817,413-69,817,666
X:57,663,647-57,664,138
13:52,260,613-52,260,773
24:15,694,097-15,694,559
17:62,843,281-62,843,815
X:43,640,390-43,640,656
5:39,939,020-39,939,274
26:3,428,348-3,428,585
15:5,881,332-5,881,851
20:48,103,437-48,103,712
2:79,096,079-79,096,475
24:35,260,072-35,260,236
1:98,778,726-98,779,224
10:52,558,495-52,558,873
1:111,515,746-111,516,031
4:12,791,804-12,792,189
3:32,111,666-32,111,915
16:22,581,974-22,582,397
11,386,498-11,386,885

Gene
symbol
--------PLP1
SPP1
SPARCL1
NISCH
LMO4
SYN2
GPM6A
DDEF1
NRN1
SNAP25
SEPT5

Gene ID
number
------5354
6696
8404
11188
8543
6854
2823
50807
51299
6616
5413

GDPD2
IGFBP7
C20orf103
MLLT11

54857
3490
24141
10962

PXMP2
PPT1

5827
5538

CAMK2N1
YWHAB
DIRAS2
CALM2
CALM3

55450
7529
54769
805
808

ATP2A2

488

Human
chromosome
---------Xq22.2
4q22.1
4q22.1
3p21.1
1p22.3
3p25
4q34.2
8q24.21
6p25.1
2p12.2
22q11.21
1q43
Xq13.1
4q12
20p12.2
1q21.2
10q23.33
17p12
12q24.33
1p34.2
19p13.11
1p36.12
20p13.12
9q22.2
2p21
19q13.32
3p21.31
15q22.2
15q14
12q24.11

Unigene
------------------Hs.1787 Cfa.3274
Hs.313
Hs.1424
Hs.435290
Hs.436792
Hs.445503
Hs.75819
Hs.106015 Cfa.10191
Hs.103291
Hs.167317
Hs.283743
Hs.433812
Hs.479808
Hs.22920
Hs.75823

Hs.430299
Hs.3873 Cfa.10158
Hs.197922
Hs.279920
Hs.165636
Hs.468442
Hs.515487

Hs.506759

Retina/brain
fold change
------------25
-20
-17
-16
-11
-9
-8
-6.5
-6.5
-6.5
-6
-6
-5
-5
-4.4
-4.2
-4
-4
-3.6
-3.6
-3
-3
-2.5
-2.5
-2.5
-2.5
-2.5
-2.5
-2.5
-2.5

Function
-----------------------------------Myelination
Phosphoprotein
Extracellular matrix protein
Cytoskeleton and cellular components
Transcriptional regulator
Neuronal phosphoproteins
Myelin proteolipid
Signal transduction
Neural activity
Synaptic activity
Nucleic acids acitivity
EST
Cell differentiation
Insulin-like growth factor
Protein precursor
leukemogenesis
Unknown
Unknown
Nucleic acitvity
Metabolism
EST
Metabolism
Signal transduction
Metabolism
Metabolism
Metabolism
EST
EST
EST
Metabolism

The top 30 genes with preferential brain expression in a retina-brain pool comparison are listed, with the corresponding identifiers, chromosomal location, expression ratio, and function. Hs represents Homo sapiens, Cfa represents Canis familiaris.
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allows comparison within and between different models of
retinal degeneration. For this purpose, a reference design was
chosen, which, ideally, would utilize a pool of normal retina
as reference. It is not possible, however, to provide a retina
pool that is large enough for the proposed scale of experiments, and, therefore, was substituted by a brain pool. The
limitation of this reference is that genes not expressed in the
brain cannot be validated against this common reference, and
common data analysis procedures, such as normalization,
might introduce experimental errors based on the tissue-specific differences. This study has validated the procedure, and
identified potential problematic genes which subsequently can
be investigated in alternate approaches such as quantitative
RT-PCR or macroarrays [26] that selectively target for analysis those genes not expressed in the brain pool.
Microarray data are most commonly normalized using
the loess algorithm, which assumes that only a small percentage of genes is differentially expressed, and maintains balance between the numbers of up- and downregulated expressed
transcripts. Alternative approaches for normalization procedures propose the use of ANOVA models [27]. This method
essentially performs only a global normalization, and does not
correct for intensity or scale differences. Yang et al. [24] have
found that the standard global median normalization can often be inadequate due to spatial and intensity dependent dye
biases, and proposed loess subgrid normalization. We have
applied different models to our data (Appendix 1), which further support these findings and suggests that we do not introduce experimental bias in the data by applying the loess subgrid
normalization.

As an initial step in evaluating the microarray, we examined gene expression pattern differences between normal retina
and the brain pool tissue reference sample. These comparisons allowed us to identify 405 out of 3,070 valid transcripts
(13.2%) as preferentially expressed in retina (Table 1), and
452 genes with low abundance in the retina (Table 2). As expected, known photoreceptor genes were highly expressed in
retina, demonstrating the specificity of the hybridization. Over
a third of the differentially expressed clones represent potentially novel genes that are enriched or even specific to retina
or brain [28]. Among the differential expressed genes were
many important to neural activity, such as ion channels (transport class) and cytoskeletal proteins (structural class). Genes
involved in more general processes, such as energy generation, also showed retina or brain preferred expression. Compared to the total number of genes with preferential expression, we found higher frequencies of proliferation and cell
death genes expressed in the brain than retina, and nucleic
acid processing genes in retina than brain. Among the transcripts preferentially expressed in the brain were many known
and unknown genes not previously reported to have a preferential expression pattern in different regions of the brain [5,29].
We demonstrated also that expression patterns are quite restricted to individual cortex areas, as few differential expressed
genes showed overlap between the examined brain regions
(Figure 2).
It is clear that, despite the common embryonic origin of
retina and brain tissues, the corresponding expression profiles
differ. Even though a subset of the genes expressed in each of
the three brain regions were unique to the tissue of origin, this

TABLE 3. GENES UPREGULATED AND EXPRESSED IN TWO OR THREE BRAIN CORTICES
Clone
identifier
-------------DR010026A10E12
DR010027A10B02
DR010023B10A04
DR010019B10C12
DR010017A10B01
DR010018B10B12
DR010023B10B01
DR010012B10B11
DR010010B20H09
DR010012A10F04
DR010009B20B10

GenBank
access
number
-------DT541032
DT541999
DT541111
DT540150
DT539606
DT539606
DT541120
DT541128
DT538497
DT538700
DT538214

Dog chromosome location
------------------------1:75,209,657-75,209,810
9:7,065,312-7,065,859
22:64,149,260-64,149,794
12:7,009,358-7,009,914
8:50,712,025-50,712,500
27:40,457,438-40,457,926
18:59,559,359-59,559,613
10:14,366,170-14,366,540
7:12,476,293-12,476,485
9:11,033,436-11,033,709
23:47,202,203-47,202,727

Gene
symbol
-------C1orf63

Gene ID
number
------57035

UPF3A

65110

KIAA0317
NECAP1

9870
25977

CPSF6

11052

TM4SF1

4071

Human
chromosome
---------1p36.11
17q24.2
13q34
6p21.31
14q24.3
12p13.31
7q21.3
12q15
14q23.1
11q13.1
3q25.1

Unigene
------------------Hs.259412 Cfa.10157
Hs.533855
Hs.497417
Hs.555927
Hs.369606

Hs.351316

Overlapping
regions
----------F-O
F-O
F-T
F-T
F-T
F-T
O-T
O-T
O-T
F-O-T
F-O-T

Function
----------------------Open reading frame
EST
Metabolism
EST
Unknown
Involved in endocytosis
EST
Nucleic acids
EST
EST
Metabolism

Hs represents Homo sapiens, Cfa represents Canis familiaris, F represents Frontal, O represents Occipital, T represents Temporal.
TABLE 4. GENES DOWNREGULATED AND EXPRESSED IN TWO OR THREE BRAIN CORTICES

Hs represents Homo sapiens; Cfa represents Canis familiaris; F represents frontal; T represents temporal; O represents occipital.
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Figure 3. Principal component
analysis illustrates differentiation of retinal gene expression
profile from the three brain regions. No variance is found
between individuals from different litters (experiment 1
[Exp.1] versus experiment 2
[Exp. 2]) or between males
(squares) and females (circles).

Figure 4. Northern blot validation of selected genes. A: Expression profile for selected
genes was obtained from
northern analysis using brain
(B), retina (R), and spleen (S)
through normalization against
the canine β-actin loading control, and compared to
microarray results (B).
NEUROD4: neurogenic differentiation 4; SYN2: synapsin II;
SPP1: secreted phosphoprotein 1.

1054

Molecular Vision 2006; 12:1048-56 <http://www.molvis.org/molvis/v12/a118/>

©2006 Molecular Vision

was proportionately a small part of the total number of genes
examined. Overall, the gene expression profiles of the three
brain regions clustered closely, when compared to the different profile obtained from retina (Figure 3). The PCA also illustrates strong similarities in each of the replicates for a given
tissue, showing the sensitivity and robustness of the custom
cDNA microarray. Particularly for the retina, we did not observe significant differences in expression profiles between
16 week old dogs based on gender or litter as has previously
been suggested from human studies [14].
Results of the microarray work were validated on northern analysis for individual transcripts (Figure 4) and confirmed
to reflect the physiology of the analyzed tissues. For example,
we found that NEUROD4 had an increased expression level
in retina compared to brain according with its function in the
developing mammalian retina [30]. CDKN1B was equally
expressed in normal retina and brain tissues; this gene encodes
a protein that binds to and prevents the activation of cyclin ECDK2 or cyclin D-CDK4 complexes, and thus controls the
cell cycle progression at G1. The microarray results also identified ESTs representing potential novel genes that showed
high preferential levels of expression in retina (e.g.,
DR010020A10D06, DR10030A20H09; Table 1). These novel
genes of still unknown function are currently under further
investigation as they may play critical roles in retinal development or maintenance, and are potential candidate genes for
retinal disorders.
Recent expression studies conducted for human retina utilized the comparisons to different tissues, such as brain, liver,
or kidney across SAGE, cDNA library, and microarray platforms [31,32]. In each case, the results yielding a few hundred retina-enriched genes can be classified into three different types: 1-genes already known to be retina enriched, such
as guanine nucleotide binding protein (GNAT1) and arrestin
(ARR3); 2-characterized genes previously not known to be
retina enriched, such as WNT inhibitory factor 1 (WIF1) and
frizzled-related protein (FRZB), and 3-unknown genes, mostly
EST clusters. Our data are not just comparable to those studies in terms of identified classes and the ratio of genes specific to the retina, but provide additional information for potential novel genes integrated in the original EST database
that allows the subsequent characterization of these transcripts
[16].
It has been suggested that genes involved in developmental
regulation of the retina are among the top candidates for degenerative processes when mutated. Recently, a microarray
profile between wild type and Nrl-/- mouse retinas produced a
list of 1,000 genes with potential high influence in rod development [33]. Among those were several genes associated with
human retinopathies (e.g., GNAT1, RHO, SAG, ROM1,
PDE6B) that have also been identified through our analysis
(Table 1, Appendix 1). Furthermore, this work presents comparable percentage of genes involved in metabolic pathways
and unknown genes, suggesting that our microarray results
are a suitable model system to address retina-specific biological questions. The results can now be extended to examine the
gene expression profiles of different canine retinal degenera-

tion models aiming to differentiate those pathways that are
unique and mutation-specific from those that are mutationindependent and common to several of the retinal disorders.
This approach will provide new insights into the molecular
mechanisms of these diseases, and help identify key molecules
and pathways for therapeutic intervention.
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